May 16, 2026 — RNews

#survivorship — Saturday, May 16, 2026 (1 items)

hot top new

← prev day next day →

0

Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4.5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network. (linkinghub.elsevier.com)

Dreyling M … Hoster E The Lancet 2026-05-16

#clinical trial #transplantation #lymphoma #survivorship #immunochemotherapy